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Abstract
The virulence protein YopM of the plague bacterium Yersinia pestis has different dominant effects in liver and spleen.
Previous studies focused on spleen, where YopM inhibits accumulation of inflammatory dendritic cells. In the present study
we focused on liver, where PMN function may be directly undermined by YopM without changes in inflammatory cell
numbers in the initial days of infection, and foci of inflammation are easily identified. Mice were infected with parent and
DyopM-1 Y. pestis KIM5, and effects of YopM were assessed by immunohistochemistry and determinations of bacterial viable
numbers in organs. The bacteria were found associated with myeloid cells in foci of inflammation and in liver sinusoids. A
new in-vivo phenotype of YopM was revealed: death of inflammatory cells, evidenced by TUNEL staining beginning at d 1 of
infection. Based on distributions of Ly6G+, F4/80+, and iNOS+ cells within foci, the cells that were killed could have included
both PMNs and macrophages. By 2 d post-infection, YopM had no effect on distribution of these cells, but by 3 d cellular
decomposition had outstripped acute inflammation in foci due to parent Y. pestis, while foci due to the DyopM-1 strain still
contained many inflammatory cells. The destruction depended on the presence of both PMNs in the mice and YopM in the
bacteria. In mice that lacked the apoptosis mediator caspase-3 the infection dynamics were novel: the parent Y. pestis was
limited in growth comparably to the DyopM-1 strain in liver, and in spleen a partial growth limitation for parent Y. pestis was
seen. This result identified caspase-3 as a co-factor or effector in YopM’s action and supports the hypothesis that in liver
YopM’s main pathogenic effect is mediated by caspase-3 to cause apoptosis of PMNs.
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Introduction
The Gram-negative bacterium Yersinia pestis is a vector-borne
pathogen that causes plague in humans. This disease manifests in
three forms, bubonic due to injection of the bacteria into the
dermis by the flea vector, pneumonic due inhalation of an
infectious aerosol, and septicemic due to systemic dissemination
within the body [1]. YopM is among a set of virulence proteins
termed Yops that function within the mammalian host. Their
genes are thermally upregulated: in the flea vector at ambient
temperature they are expressed at low basal levels, whereas they
are strongly expressed once within mammalian tissues. Additional
thermally upregulated virulence properties that function alongside
and in conjunction with the Yops are adhesins, anti-phagocytic
fibrils, and an under-acylated lipooligosaccharide that evades pro-
inflammatory signaling through Toll-like receptor 4 (TLR4) [2–4].
The Yops are delivered to the cytosol of mammalian cells by a
type 3 secretion system (T3SS). There they inhibit signaling
pathways involved in phagocytosis and development of inflam-
mation [5]. Overall, the Yops function early in infection to
counteract innate defenses and thereby promote bacterial repli-
cation to the overwhelming numbers needed for transmission to a
flea vector in a blood meal.
YopM has a leucine-rich repeat structure without obvious
enzymatic domains and is believed to function as a scaffold that
binds host proteins [6,7]. Two serine/threonine kinases, ribosomal
protein S6 kinase one (RSK1 or p90RSK) and protein kinase C-
like (PRK or PKN) are bound to YopM in large complexes and,
despite being activated in the complex, fail to activate their usual
downstream targets [7–9]. YopM also inhibits the cysteine
protease caspase-1. This prevents inflammasome maturation and
limits release of the pro-inflammatory cytokines IL-1 and IL-18
[10]. YopM’s effect on either RSK1 or caspase-1 promotes
virulence of the bacteria [9,10]; however it is not known if or how
these effects are linked biochemically. Interactions of YopM with
serum proteins have been documented; but these have not been
found to have significant effects on virulence, likely because most
of YopM is delivered into cells without release into extracellular
fluid [11–14]. Pure YopM can promote its own entry into cells
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[15]. Once inside either spontaneously or via the T3SS, YopM
traffics to the nucleus in a process that is promoted by vesicular
trafficking [14,15]. Accordingly, YopM’s effects could involve
multiple host molecules in both cytoplasm and nucleus.
In a mouse model of systemic plague, intravenously (IV) injected
Y. pestis KIM5 seeds liver and spleen within 30 minutes [16] and
replicates. If the strain lacks YopM, a host response curbs net
growth beginning , d 2 post-infection (p.i.). In infected spleen,
that time point marks the beginning of a progressive qualitative
shift in populations of inflammatory cells [17,18]. Mice infected
with the parent YopM+ Y. pestis KIM5 showed loss of
inflammatory MOs and iDCs as well as natural killer (NK) cells
from spleen in contrast to ones infected with DyopM-1 Y. pestis,
where these cells accumulated in spleen [17–19]. The critical cells
for controlling DyopM-1 Y. pestis in spleen proved to be the
inflammatory MOs and DCs, not NK cells or PMNs, which were
dispensable for limiting growth of the bacteria in spleen [18,19]. In
contrast to spleen, livers of Y. pestis-infected mice did not show
YopM-associated differences in recruitment of MOs, iDCs, or NK
cells. Recruitment of PMNs also was not affected by YopM;
however, PMNs were critical for controlling growth of DyopM-1 Y.
pestis in liver [18,19]. It was hypothesized that in liver, YopM
inhibits PMN antibacterial function. Further, when parent Y. pestis
was co-infected with DyopM-1 Y. pestis, the parent strain protected
the mutant from growth limitation in spleen but not in liver [18].
These results were consistent with the interpretation that in spleen
YopM prevents accumulation of a mobile component that is anti-
bacterial (iDCs), whereas in liver, the bacteria act directly, one-on-
one, against antibacterial host cells [18,19]. Accordingly, YopM
has different critical effects in the two organs.
Previous studies on YopM function have emphasized spleen
over liver; yet liver has the advantage of a highly regular
architecture within which inflammatory cells are easily distin-
guished; and the populations of inflammatory cells do not differ
between infections by parent and DyopM-1 Y. pestis. We report
here studies that revealed a pathogenic effect of YopM unique to
liver and an element of a pathway in which YopM functions.
Materials and Methods
Ethics statement
All animal experiments in this study were reviewed and
approved by the University of Kentucky Institutional Animal
Care and Use Committee. The protocol under which the work
was conducted was Number 2007–0077, ‘‘YopM and Protective
Innate Defenses against Plague’’. Mice were anesthetized during
infection procedures, infected mice were checked twice daily for
signs of illness, and they were humanely killed by CO2 inhalation
followed by cervical luxation. They were not allowed to die of
plague.
Bacterial strains and in vitro cultivation
This study employed Y. pestis KIM5 (molecular grouping
2.MED), an isolate from Iran, and the DyopM-1 derivative KIM5-
3002. They lack the chromosomal pgm locus and are conditionally
virulent: attenuated from peripheral routes of infection but
virulent by the IV route of infection, which bypasses the
requirement for a siderophore-based iron-acquisition mechanism
encoded in this locus [20]. Two growth protocols were used for Y.
pestis KIM5-derived strains. The bacteria were grown at 28uC for
at least 6 generations at exponential phase in Heart Infusion Broth
(HIB, Difco Laboratories) and harvested in exponential phase at
A620 = 0.8 to 1.2 or, after 6 generations in exponential phase at
28uC they were transferred to 37uC at A620 of ca. 0.3 and
incubated for 3 h (28/37uC). For infection of mice, cells were
centrifuged at 23,0006g and 4uC for 5 min and then washed and
diluted in phosphate-buffered saline (PBS). Samples from the
dilutions were plated on tryptose blood agar (Difco Laboratories)
and incubated at 30uC for 2 d to determine the actual dose.
Infection of mice and measurement of bacterial viable
numbers in tissues
All mice used were female and 6–12 weeks of age. The majority
of experiments used C57BL/6N.HSD mice (B6; Harlan Sprague
Dawley, Inc). Some experiments used transgenic mouse strains on
a C57BL/6 background (The Jackson Laboratory): mice lacking
inducible nitric oxide synthase (iNOS) (B6.129P2-Nos2tm1Lau/J)
and mice lacking caspase-3 (Casp32/2) (B6.129S1-Casp3tm1Flv/J).
Mice were anesthetized with an isoflurane-oxygen mixture by a
rodent anesthesia machine. The specified number of CFU of Y.
pestis in 50 mL was injected in each mouse IV via the retro-orbital
plexus. At designated times after infection, groups of mice were
humanely killed by CO2 inhalation followed by cervical luxation,
and their spleens and livers were transferred to a sterile bag
containing 5 mL of PBS and homogenized in a Stomacher 80 lab
blender (Tekmar Co.). When portions of livers were to be used for
histology and the rest for determination of viable bacterial
numbers, the livers were handled singly. Each liver was weighed,
the portion for histology was removed, and the remainder was
weighed again and homogenized. The liver and spleen homog-
enates were diluted in pH 11 water followed by further dilutions in
PBS. Samples were plated to measure viable bacterial numbers
(CFU) in the organs, corrected as necessary for removed portions
of livers.
Because we used bacteria pre-grown at 28/37uC in addition to
28uC in some experiments we determined the extent to which
thermal pre-induction affected virulence. The LD50 values were
measured for 28uC- and 28/37uC-grown DyopM-1 Y. pestis
KIM5-3002 in B6 mice. An initial test with 10-fold dilutions of
bacteria established the dose range to be used. Then groups of 8
mice were given serially 3-fold diluted bacterial doses. The mice
were observed twice daily for mortality for 14 d. Mice that had
become prostrate and deemed, from experience, not likely to
survive to the next observation were humanely killed, and their
death was recorded as of the following observation. The LD50 was
determined by probit analysis of the survival data. The LD50 of the
28/37uC-grown DyopM-1 mutant was 5626104, ca. 4-fold lower
than that for the same strain grown at 28uC (2616105). This
result confirmed that there was a measurable but small difference
in lethality due to the incubation at 37uC.
PMN ablation
PMNs were ablated with the PMN-specific anti-Ly6G mAb
(mAb 1A8; Bio 6 Cell); control mice received rat IgG (Sigma-
Aldrich Co.). The antibodies were injected intraperitoneally as
200 mg/mouse in 100 mL PBS on d –1 and +1 of Y. pestis
infection. The extent of ablation in these and in mock-treated mice
on d 1 to d 3 p.i. was shown to be 88% to 99% by flow cytometry
with detection via fluorochrome-tagged anti-Ly6G and anti-
CD11b antibodies (see below).
Flow cytometry
Leukocytes were analyzed in a FACSCalibur flow cytometer
(Becton Dickinson FACS Systems) as described previously [18].
Briefly, splenic leukocytes were centrifuged and resuspended in
2 mL RBC lysis buffer (150 mM NH4Cl, pH 7.2). After 2 min,
the lysis was terminated by addition of 8 mL of PBS. The cell
Y. pestis YopM Function in Liver
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suspensions were filtered through a 40 mm-pore-size cell strainer
(Becton, Dickinson and Company), centrifuged, and resuspended
in PBS containing 1% (wt/vol) BSA and 0.1% (wt/vol) sodium
azide (PBS-BSA-azide). Minced livers in 10 mL RPMI 1640 (Life
Technologies Corp.) with 10% fetal bovine serum (FBS; ATCC)
were processed with a Stomacher 80 lab blender. Samples were
removed to plate for CFU, and the remaining homogenates were
incubated with DNase I (160 U/mL, Sigma-Aldrich) and
collagenase (400 U/mL, Life Technologies) for 30 min at 37uC
with shaking at 125 rpm. After filtration through a 40 mm-pore-
size cell strainer, cell suspensions were washed once with ice-cold
PBS-BSA-Azide and resuspended with 5 mL 33.8% Percoll
(Amersham bioscience, GE Healthcare) followed by centrifuga-
tion. The cells in the bottom layer were collected, washed with
PBS, treated with RBC lysis buffer, and resuspended in PBS-BSA-
azide.
The following antibodies were purchased from BD Pharmingen,
Inc.: allophycocyanin (APC)-conjugated anti-CD11c, Fluorescein
isothiocyanate (FITC)-conjugated anti-CD11b, Phycoerythrin
(PE)-conjugated anti-Ly6G, and Fc Block (Rat Anti-Mouse
CD16/CD32). To gate out apoptotic or dead cells, ethidium
monoazide (EMA, Sigma-Aldrich) was used for viability staining.
Prior to staining, the cells were counted, and samples were
adjusted to 56106 cells per mL. Then they were stained as
described previously [18]. Briefly, after treatment with Fc Block
for 15 min on ice, the cells were incubated with appropriate
combinations of antibodies and EMA on ice for 30 min, with the
last 10 min of incubation being in the light. After being washed in
PBS, they were resuspended in ice-cold PBS containing 4% (wt/
vol) paraformaldehyde (pH 7.4) for at least 30 min before flow
cytometric analysis.
Flow cytometric processing was performed by the Flow
Cytometry Core Facility at the University of Kentucky. The data
were analyzed with WinMDI (Version 2.7; Joseph Trotter, Salk
Institute for Biological Studies, La Jolla, CA [available at http://
facs.Scripps.edu/software.html]).
Immunohistochemistry for cell-surface markers
Livers and spleens were nicked several times with a scalpel
blade, fixed overnight in 10% (vol/vol) buffered formalin (Fisher
Scientific Inc.) or Histochoice MB (Electron Microscopy Sciences),
and transferred to 70% (vol/vol) ethanol. They were dehydrated
and paraffin-embedded by Cynthia Long in the University of
Kentucky Imaging Core Facility. 5-mm-thick sections were cut,
deparaffinized with xylene, rehydrated through a graded ethanol
series, and stained with hematoxylin and eosin (H&E). The general
immunohistochemistry (IHC) procedure was as follows. Depar-
affinized sections were rinsed in tap water 1 min and submerged
20 min in hot citrate buffer (5 mM Na citrate.2H2O+1% [vol/vol]
Tween 20 pH 6.0) in a coplin jar within a vegetable steamer
(antigen retrieval step). The coplin jar was removed to room
temperature and allowed to stand, uncapped, 30 min. The citrate
buffer in the jar was replaced, and the slides were rinsed with
warm water for several minutes (more than 2 complete changes)
and then treated with 3% (vol/vol) H2O2 5 min to saturate
background peroxidases. Slides were rinsed with PBS, incubated
in PBS 5 min, and blocked 1 h at room temperature (PBS +
FcBlock +10% [vol/vol] normal serum [NS] +1% [wt/vol]
histochemical grade BSA [Vector Laboratories]). Sections were
then covered with primary antibody (1o Ab; in PBS +1% [wt/vol]
histochemical grade BSA) and incubated overnight at 4uC in a
humidor. If the 2o Ab was from rat, it was first adsorbed for
30 min at 4uC with 1% (wt/vol) acetone powder prepared from
mouse livers and spleens and then clarified by centrifugation. The
slides were given two 5-min washes with water and stained with
biotinylated secondary antibody (2o Ab) 30 min at room
temperature. They were stained by using Vectastain ABC
(avidin/biotinylated enzyme complex; Vector), developed with 3,
39-diaminobenzidine (DAB; Sigma-Aldrich), counterstained 1 min
with hematoxylin QS (Vector), rinsed 1 min in water (until water
ran clear), cleared through ethanol and xylenes, and mounted.
Protocol details were optimized for each antibody and organ. For
F4/80, blocking NS was rabbit (Invitrogen Corp./Life Technol-
ogies), 1o Ab was rat monoclonal BM8 (eBioscience) diluted 1:500
(liver) or 1:800 (spleen), and 2o Ab was mouse-adsorbed
biotinylated anti-rat IgG (Vector Laboratories) diluted 1:100.
For iNOS, blocking NS was goat (Invitrogen Corp./Life
Technologies), 1o Ab was rabbit polyclonal anti-iNOS (Abcam;
cat. No. ab15323) diluted 1:150 (liver) or 1:200 (spleen), and 2o Ab
was biotinylated anti-rabbit IgG (Vector Laboratories) diluted
1:250. For Ly6G, blocking NS was rabbit, 1o Ab was rat
monoclonal 1A8 (BD Pharmingen) diluted 1:1000 (liver) or 1:1500
(spleen), and 2o Ab was mouse-adsorbed biotinylated anti-rat IgG
diluted 1:250. For ‘‘capsular’’ antigen F1 on Y. pestis, blocking NS
was goat, 1o Ab was mouse monoclonal YPF19 (Abcam cat.
No. ab8275) diluted 1:100, and 2o Ab was biotinylated anti-mouse
IgG (Vector Laboratories) diluted 1:250. We also used as 1o Ab a
rabbit anti-37uC-grown Y. pestis KIM6-whole-cell antibody
diluted 1:1000 (liver) or 1:250 (spleen) with biotinylated anti-
rabbit IgG 2o Ab diluted 1:250 and obtained similar results.
Histochoice fixation resulted in better staining for F4/80 and
iNOS than fixation by formalin.
TUNEL assays were carried out on formalin-fixed paraffin-
embedded sections as follows. Deparaffinized sections were rinsed
in tap water 1 min and submerged 10 min in hot citrate buffer
(5 mM Na citrate.2H2O +1% [vol/vol] Tween 20 pH 6.0) in a
coplin jar within a vegetable steamer (antigen retrieval step). The
coplin jar was removed to room temperature, 25 ml of room-
temperature PBS was added, and the slides were immediately
transferred to fresh PBS for 5 min followed by a second 5-min
soak in PBS. Slides were then blocked 1 h at room temperature
(PBS +20% [vol/vol] heat-inactivated FBS +1% [wt/vol] BSA).
They were washed by two 2-min changes of PBS, liquid drops
were removed withabsorbent paper, and then sections were
covered with rat anti-BrdU (1o Ab; Abcam Ab6236) diluted 1:40
in the Strep Dilution Buffer from the Trevigen TACS XL in situ
apoptosis detection kit and incubated overnight at 4uC in a
humidor. The slides were given two 5-min changes of PBS, liquid
drops were blotted, and then sections were covered with mouse-
adsorbed biotinylated rabbit anti-rat IgG (2o Ab) diluted 1:250 in
Strep Dilution Buffer or PBS +1% BSA and incubated 2 h at room
temperature in a humidor. Slides were given three 5-min changes
of PBS. Subsequent steps were performed in the dark. Sections
were covered with Oregon green-conjugated neutravidin (Invitro-
gen Molecular Probes) diluted 1:250 in Strep Dilution Buffer and
incubated 1 h at room temperature in a humidor. The slides were
given three 5-min soaks in PBS, blotted, mounted with Vectashield
(Vector) containing 0.143 mM 49, 6-diamidino-2-phenylindole
(DAPI), and sealed with nail polish.
Sections were examined with a Nikon Eclipse E800 microscope
and photographed with a Photometrics CoolSNAP cf camera.
Sections were scanned and fields were photographed systemati-
cally. Size markers were inserted into images by the Nikon NIS
Elements v 3.22 software. These aided measurements of the widest
aspect of inflammatory foci for purposes of classification into
arbitrary categories of small, medium, and large (,50 mm, 50–
100 mm, and.100 mm, respectively). In tissue sections stained by
the TUNEL reaction, foci were first identified by the presence of
Y. pestis YopM Function in Liver
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densely clustered nuclei stained with DAPI, and then TUNEL
staining was recorded. TUNEL-stained foci were analyzed for the
percent of area occupied by staining over a threshold value that
excluded nonspecific background staining by using MetaMorph v.
5.0 r7 software (Universal Imaging Corp.). Figures were composed
with Adobe Photoshop CS5.
Statistical analysis
Infection experiments were conducted at least twice with at least
3 replicate mice per group. Supportive data are given in Table S1
and Figure S1. The numbers of mice used for each datum point
are given in the figure legends. Significance of differences among
groups was assessed by the Student’s 2-tailed unpaired t test.
Values for P,0.05 were considered significant. The LD50 and
95% confidence intervals were determined from the probit
analysis of the mortality data (Biostat software, Analystsoft.com).
Categorical distributions of cells within lesions were compared for
difference by using a 2-tailed Fisher’s exact test, which determines
whether the odds ratio is significantly different from 1. P Values ,
0.05 were considered significant.
Results and Discussion
Cells directly associated with Y. pestis in liver
We had shown that PMNs are critical for control over growth of
28uC-grown DyopM-1 Y. pestis in liver [19]. In this study we
verified that this also holds when the bacteria were grown at 28/
37uC (Figure 1). In one of the experiments of Fig. 1, we evaluated
the histology in each of the 3 mice per treatment group on each of
the three days. Figure 2 illustrates typical lesions for d 3 p.i. in
mice with bacterial burdens near to the means of the pooled data
of Figure 1. In mock-treated mice, parent Y. pestis formed
compact coagulatively necrotic lesions with only bits of inflam-
matory cells remaining (Fig. 1A), while foci due to the DyopM-1
strain in mock-treated mice were larger and retained many intact
cells (panel C). In mice ablated for PMNs (panels B and D), the
lesions due to both strains were similar to ones due to DyopM-1 Y.
pestis in mock-treated mice. These findings are consistent with the
critical involvement of PMNs in cellular destruction as previously
found in pneumonic plague, where PMNs were shown to be
responsible for the architectural damage and major symptoms of
disease [21]. Further, it was striking that the extensive destruction
of inflammatory cells was seen only when the bacteria expressed
YopM and the mice had PMNs (Fig. 2 panel A), even though
similarly high bacterial numbers were present in livers of the
PMN-ablated mice infected with parent Y. pestis (panel B).
Our previous studies had indicated that in liver YopM
undermines PMN antibacterial function without a diffusible
mediator [19]. This could occur through direct binding and
delivery of YopM to PMNs or through delivery of YopM to a cell
such as a KC that PMNs must directly interact with to have their
antibacterial effect. To establish the context in which YopM
functions early, we used IHC to identify inflammatory cells and
locate Y. pestis in livers of B6 mice infected for 17 h with thermally
pre-induced Y. pestis KIM5 at a dose high enough (106 or 107) that
bacteria would be found in thin sections. Figure 3A shows that
these early inflammatory foci were populated by PMNs, which
tended to be evenly distributed as illustrated (based on nuclear
morphology in H&E-stained sections from 4 experiments and
Ly6G staining in the experiment of Figure 3: see Table S1). F4/
80+ cells (Kupffer cells [KCs] and MOs) were scattered in
sinusoids and clustered around foci (Fig. 3B). If the focus was
small, they tended to be present over the entire focus (,70% of
such foci), but in larger foci they were restricted to the periphery
(,84% of such foci) (quantification is given in Table 1 and Table
S1). This observation indicates that as foci enlarge, KC/MOs are
lost from the centers.
Within the foci, clusters of bacteria were associated with groups
of inflammatory cells (Fig. 3C). In the sinusoids, bacteria were
associated with PMNs (Fig. 3D) and mononuclear cells (KCs/
MOs/DCs; Fig. 3C, E and F) and not with endothelial cells or
hepatocytes. Similar observations were made at d 2 p.i. in mice
infected with a lower dose as in Figures 4 and 5 (data not shown).
These observations show that Y. pestis interacts directly with
myeloid cells in liver, including PMNs. Following IV infection, the
bacteria would seed the liver via the hepatic artery, which mixes
with the input of the hepatic portal vein and flows into the
sinusoids to bathe the liver plate hepatocytes. The bacteria could
bind to KCs that patrol the sinusoids and to PMNs that are rapidly
Figure 1. PMNs were critical to control growth of 28/376C-
pregrown DyopM-1 Y. pestis in liver but not spleen. B6 mice were
ablated for PMNs (open symbols) by treatment with anti-Ly6G antibody
on days -1 and +1 of infection; mock-treated mice (closed symbols)
received nonspecific rat IgG. The mice were infected with 400 28/37uC-
grown parent (squares) or DyopM-1 (circles) Y. pestis, and viable
numbers (CFU) were determined on d 1, 2, and 3 p.i. Group labels: MM,
mock-treated mice infected with DyopM-1 Y. pestis; AM, Ablated mice
infected with DyopM-1 Y. pestis; MP, mock-treated mice infected with
the parent strain; AP, ablated mice infected with the parent strain. The
data were obtained in two experiments, each with 2 to 3 mice per
group, for 4 to 6 mice total for each category. Each symbol gives the
bacterial burden of one mouse; the horizontal lines mark the geometric
means of the pooled data for each category. Statistically significant
differences by Student’s t test occurred on d 3 p.i. as indicated: *, P,
0.05; **, P,0.01.
doi:10.1371/journal.pone.0110956.g001
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attracted to the site. These are the first cells in liver that would be
receiving YopM, consistent with findings for spleen, lung, and skin
[21–23], showing that macrophages and PMNs are the earliest
cells with which Y. pestis interacts.
YopM promotes cell death
Our previous histopathologic observations on livers of mice 4 d
after infection by a low dose (100) of 26uC-grown DyopM-1 Y.
pestis found that in liver, inflammatory cells in foci remained
morphologically intact longer than those due to the parent strain
[17]. In the present study, mice were infected in two experiments
that used doses ,2-fold below the LD50 for DyopM-1 Y. pestis
grown either at 28uC or 28/37uC. We stained infected tissues for
presence of DNA strand breaks by terminal deoxynucleotidyl
transferase dUTP nick end labeling (TUNEL). This assay will label
cells in a late stage of apoptosis or pyroptosis. After infection with
105 28uC-grown parent or DyopM-1 Y. pestis, sections of livers and
spleens from two mice for each strain were stained and quantified.
On d 1 p.i., when lesions were small, virtually no TUNEL staining
was observed in livers infected with the DyopM-1 strain, whereas
some staining was found for livers infected by the parent strain
(data not shown). By d 2 p.i. when inflammatory foci were
prominent, judging from the distributions of DAPI-stained nuclei,
there was much more TUNEL staining in liver foci due to parent
than DyopM-1 Y. pestis, (Fig. S1 panels A-D). The fraction of focus
area occupied by TUNEL staining in foci due to parent Y. pestis
was 8.064.8% (based on 21 foci), whereas foci due to the DyopM-
1 strain were 2.661.8% TUNEL+ (based on 32 foci), a difference
that was statistically significant (2-tailed t test: P = 7.161027). This
assay was repeated on single mice infected 2 d with 36104
thermally induced parent or mutant Y. pestis with similar results
(Fig. 4A-D): foci due to parent Y. pestis were 10.867.3% TUNEL+
(based on 44 foci), whereas those due to the DyopM-1 strain were
3.963.6% TUNEL+ (based on 28 foci), again statistically
significant (2-tailed t test: P = 1.661025).
It was not possible to identify the TUNEL+ cells by their nuclear
morphology, because TUNEL-staining nuclei were highly con-
densed or fragmented, and apoptotic PMN nuclei lose their
multilobed structure [24]. However, the distribution of TUNEL+
nuclei was similar to the cellular distribution for PMNs and distinct
from that for mononuclear cells. The TUNEL staining tended to
be evenly distributed or centrally located (86%–93% of foci for the
two strains in the two experiments). PMNs also tended to be evenly
or centrally distributed in all sizes of foci. 90% of foci that
contained TUNEL+ nuclei were medium to large, and staining
only rarely was restricted to the edge (10% of TUNEL+ foci);
whereas F4/80 cells were restricted to the edge of half to two-
thirds of medium to large foci. These findings could be taken as
support for the hypothesis that most of the TUNEL+ cells were
PMNs that underwent cell death in response to YopM delivery in
addition to some spontaneous apoptosis and phagocytosis-induced
apoptosis [24]. However, the dead cells represented ones that had
been present there earlier when the lesion was smaller, and F4/80+
cells were present uniformly in small foci along with PMNs.
Hence, we cannot rule out a process in which F4/80+ cells initially
were recruited but then killed as the lesion enlarged, resulting in
peripherally-arranged F4/80+ cells in medium to large foci with
centrally or uniformly distributed TUNEL staining. Accordingly in
Figure 2. Destruction of inflammatory cells correlated with the presence of both YopM and PMNs. Portions of livers from all mice in one
of the experiments of Figure 1 were fixed in formalin, sectioned, and stained with H&E. Lesions are illustrated for d 3 p.i. in mice with bacterial
burdens similar to the means of the pooled data of Figure 1. Panel A, mock-treated mouse infected with parent Y. pestis (26106 CFU in liver); panel B,
PMN-ablated mouse infected with parent Y. pestis (16106 CFU in liver); panel C, mock-treated mouse infected with DyopM-1 Y. pestis (76104 CFU in
liver); panel D, PMN-ablated mouse infected with DyopM-1 Y. pestis (56105 CFU in liver). Arrows point to inflammatory lesions. The bars represent
100 mm.
doi:10.1371/journal.pone.0110956.g002
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liver, infection with Y. pestis promotes YopM-associated death of
inflammatory cells, probably both PMNs and KC/MOs, detect-
able as early as d 1 p.i. and prominent by d 2. TUNEL staining
can result from oncosis and pyroptosis as well as apoptosis [24];
accordingly, further biochemical and cell biological assays will be
required to identify which of these cell death mechanisms is
stimulated by YopM in liver [25].
In spleen, similar amounts of TUNEL staining were seen for
infections with parent and DyopM-1 Y. pestis, (illustrated in
Fig. 4E and F). The foci were more clearly demarcated in mice
infected with 105 28uC-pregrown yersiniae (Figure S1E and F),
and quantification indicated nearly identical amounts of staining
per focus, with the caveat that this was based on only 6 or 7 lesions
for each infecting strain. Accordingly, YopM-associated cell death
is a phenotype unique to liver. YopM may promote cell death in
spleen as well as liver, although in spleen this activity apparently is
redundant to a YopM-independent effect.
iNOS+ cells invaded inflammatory foci by d 2 p.i.
Because of the known importance of iMOs and iDCs for
YopM’s pathogenic effect in spleen, we evaluated the distribution
of these cells in liver by staining for inducible nitric oxide synthase
(iNOS), which these cells express strongly. Mice were infected with
104 to 36104 thermally induced parent or DyopM-1 Y. pestis, and
livers were obtained for IHC. In one of the experiments, one
mouse infected with each strain was analyzed after 24 h. At this
time, most foci lacked iNOS staining or contained only 1 to 3
iNOS+ cells (data not shown). We therefore focused further study
on mice infected 48 h, when iNOS staining was prominent. IHC
for iNOS+ cells showed distinct patterns from those described
above for F4/80+ cells and provided insight into the structure of
the inflammatory foci (Figure 5 and Table 2). iNOS was detected
in cells that infiltrated the medium to large lesions; and in the
interior of larger foci where staining for F4/80 was sparsely
present, the iNOS-producing cells were prominent (Fig. 5A vs.
5C, Table 2 for iNOS, and Table S1 for F4/80). Conversely, $
50% of small foci that tended to be covered with F4/80+ cells
lacked iNOS+ cells (Table 2 for iNOS and Table S1 for F4/80).
Further, the iNOS+ cells were distributed differently from PMNs
(Fig. 5D and Table S1) and were mononuclear. Accordingly,
iNOS-production could not be assigned to either PMNs or F4/80+
cells.
The iNOS+ cells could often be seen to have numerous thin
processes (illustrated in Fig. 5B) and likely represented iDCs,
Figure 3. Early in infection many Y. pestis KIM5 bacteria were associated with inflammatory cells including PMNs. Mice were infected
IV for 17 h with 107 28/37uC-grown Y. pestis KIM5. Sections of formalin-fixed paraffin-embedded livers were stained with cell- or Y. pestis-specific
antibody, developed with DAB (black or brown), and counterstained with hematoxylin. Antibodies used were: Panel A, anti-Ly6G (for PMNs); Panel B,
anti-F4/80 (for KCs and MOs); Panels C and D, anti-Y. pestis antibodies; Panels E and F, the YPF19 monoclonal antibody against the F1 fibril. Solid
arrows in panels A and B indicate foci of inflammation; open arrows indicate either small foci or ‘‘polar cap’’ (tangential) sections of foci. The arrow in
panel C points to a bacterium on a mononuclear cell adjacent to a focus where numerous bacteria were contained in the plane of the section. The
arrow in panel D indicates several bacteria associated with PMNs in a hepatic sinus. Arrows in panels E and F point to bacteria associated with
mononuclear cells. The bars in panels A and B represent 100 mm; in panels C-F, the bars represent 10 mm.
doi:10.1371/journal.pone.0110956.g003
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which are known to lose expression of the F4/80 surface marker
previously present on their precursor MOs [26] and are known to
appear in liver and spleen by d 2 of infection [19]. The
distributions of these cells did not differ significantly between
infections by the two Y. pestis strains within small and large foci.
This accounts for the majority of foci analyzed (76% for DyopM-1
and 87% for the parent strain). For the medium-sized foci, those
due to the DyopM-1 strain tended more to an invasive distribution
of iNOS+ cells and less frequently lacked these cells than foci due
to parent Y. pestis. This observation is tantalizing, because iDCs
are important in conditioning the local inflammatory environment
to promote activation of macrophages and PMNs and could
contribute to the lower net growth of the mutant compared to the
parent strain seen by d 2 of infection. However, the difference was
only just below the cut-off for statistical significance and did not
persist or intensify as foci became large. We suspect it is not
biologically significant. The NO produced within inflammatory
foci was not responsible for the growth difference between parent
and DyopM-1 Y. pestis, because both parent and DyopM Y. pestis
strains grew to ca. 10-fold higher numbers in livers of mice lacking
iNOS (B6.129P2-nos2tm1Lau/J) (data not shown), showing that NO
per se has an equally negative influence on the growth of both
strains in liver.
Taken together, the histological observations at 48 h p.i. with
,104 thermally-induced Y. pestis found foci uniformly or centrally
dominated by PMNs. KC/MOs had disappeared from the centers
of at least half of medium-sized foci, and only weakly staining ones
remained at the edges of large foci. Cells that could be iDCs had
developed at the periphery and were penetrating the interior.
Their outside-toward-in distribution suggests that their precursors
derived from blood and not from endogenous liver F4/80+ cells
that appeared early in infection in the interiors of foci. Dying cells
were present in the centers or scattered uniformly throughout the
foci at d 2 p.i., with significantly greater numbers of these in foci
due to the parent strain. This finding represents a YopM-related
phenotype: YopM delivered to inflammatory cells in the centers of
foci resulted in cell death. This would be a direct effect of YopM
on the cells that receive it, as we previously found that YopM’s
effect on its target cell does not involve a diffusible/mobile
mediator in liver [19]. It is worth noting that hepatocytes undergo
apoptosis during the process of coagulative necrosis due to
inflammation in both infective and non-infective liver damage
[27,28]. Coagulative necrosis is distinctly more evident in the case
of infection by parent Y. pestis than the DyopM strain by d 3 p.i.
(Fig. 2 A and C) and correlated with the bacterial burden. On d 3,
when viable numbers of the parent strain are significantly higher
than than those of the mutant (Fig. 1, Day 3, closed symbols).
However, at d 2 p.i., when the TUNEL studies were done, lesions
due to the two strains did not show this large a difference in
character, likely because the numbers of the two strains were more
similar at that time (Fig. 1, Day 2, closed symbols; and data not
shown for the experiment of Fig. S1). Accordingly, although we
have not directly excluded a contribution from dying hepatic cells
to the TUNEL staining, we believe this was not responsible for the
differences we found. We hypothesize that the cells directly
affected by YopM in liver are the KCs that are present in centers
of foci as well as PMNs, and that this alters the inflammatory
character of the focus in favor of survival and growth of the parent
strain in the face of immigrating iDCs.
Tests with caspase-32/2 mice revealed a host factor with
which YopM might act
We tested for a role of caspase-3, an ‘‘executioner’’ cysteine
protease that mediates apoptosis, because of the correlation
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between the presence of YopM in the infecting strain and greater
cell death in liver. We used a low IV dose (100 to 500 bacteria) of
28uC grown Y. pestis as in previously published experiments with
mice ablated for different innate immune cells [17–19] and
analyzed CFU in liver and spleen at d 3 p.i. when differences
between parent and DyopM-1 Y. pestis numbers are large in
wildtype mice. Figure 6 shows that in livers of these mice, growth
of parent Y. pestis was restricted and resembled that of the DyopM-
1 strain, which was not altered by the absence of caspase-3.
Growth of the parent strain was also inhibited in spleens of the
Casp32/2 mice, whereas the DyopM-1 strain was not affected
significantly; however, there remained some difference in viable
numbers between parent and mutant strains in spleens of Casp32/
2 mice. This pattern of growth inhibition for the parent strain but
not the DyopM-1 mutant in knockout mice is distinct from that for
loss of a target cell for YopM such as PMNs or a downstream
molecular target such as caspase-1 [10,19], where growth of the
DyopM-1 mutant is preferentially enhanced. These findings
represent the discovery of an effector arm of YopM’s pathogenic
mechanism: YopM requires the presence of caspase-3 to function
in both organs. Caspase-3 could be viewed as a cofactor for
YopM. Loss of a cofactor molecule in effect inactivates YopM, and
YopM+ bacteria would grow like the YopM- strain, while YopM-
bacteria that lacked YopM in the first place would not be affected
by absence of a host cofactor. Apparently, without caspase-3, an
anti-bacterial host function is active against the parent as well as
DyopM-1 yersiniae. We hypothesize that in liver, this function
would be activated PMNs. Although the bacteria also bind to KC/
MOs which do disappear from centers of enlarging foci, the death
of these cells could mainly be due to YopJ, which is known to
cause apoptosis in MWs [29]. In contrast, PMNs do not undergo
apoptosis in response to YopJ [30]; hence YopM’s apoptosis-
Figure 4. YopM caused death of inflammatory cells in liver. Mice were infected 2 d with 36104 thermally pre-induced parent Y. pestis KIM5 or
the DyopM-1 strain. Liver and spleen sections were stained by the TUNEL reaction to reveal cells undergoing DNA fragmentation. Panels A, C, E, and F
show TUNEL+ staining by bright green fluorescence. Panels B and D show the same sections as panels A and C stained for DNA by DAPI (blue
fluorescence) to reveal the distribution of cells by their nuclei. Foci were identified based on such nuclear accumulations. The boundaries of the foci
were outlined on the DAPI images using tools within the morphometrics software and transferred to the corresponding positions in the TUNEL
images. The areas within the outlines were used by the morphometrics program for quantification of TUNEL staining. For this illustration, the outlines
were traced within the Photoshop program to make them 5 pixels thick. The bars represent 100 mm.
doi:10.1371/journal.pone.0110956.g004
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inducing effect may be manifested most strongly on PMNs in liver
as indicated previously by cell-depletion studies [19]. In spleen,
YopM inhibits recruitment of iDCs, presumably in addition to
promoting apoptosis of PMNs; hence YopM retains partial
function there in the absence of caspase-3.
Figure 7 illustrates foci in mice that had bacterial burdens equal
to the mean CFU values of Figure 6. Panels A and C show the
difference in control B6 mice infected by parent and DyopM-1 Y.
pestis where there is a 100-fold difference in bacterial burden in
the presence of PMNs (documented also in [18]): the centers of
foci in livers of control B6 mice infected with parent Y. pestis
contained noticeably greater numbers of fragmented and con-
densed nuclei than foci due to the DyopM-1 strain. In contrast,
inflammatory cells in livers of Casp32/2 mice infected by the two
strains showed a less striking difference, with many intact nuclei
remaining, even in the infection by parent Y. pestis (Fig. 7B and
D). The decreased bacterial burden of the parent strain in
Casp32/2 mice indicates that the virulence of the parent Y. pestis
was decreased in these mice. The B6 mice, with.106 CFU per
liver, would all have died had we waited several more days,
whereas only 1 Casp32/2 mouse of the 6 analyzed in full and 2 of
6 more from a pilot experiment had such high CFUs in these
experiments. In such instances, the foci in the Casp32/2 mice
resembled those of Fig. 7A (B6 mice), with only scattered bits of
inflammatory cells remaining (data not shown). This situation did
not occur in infections by the DyopM mutant, and it is possible that
the parent strain, despite its reduced virulence, still was more
virulent than the DyopM-1 strain in Casp 32/2 mice. Accordingly,
YopM may also have caspase-3-independent virulence effects, in
agreement with the finding in Fig. 6 of greater viable bacterial
numbers in spleens of Casp32/2 mice infected by the parent strain
than by the DyopM-1 strain.
Summary and Further Discussion
This study sought improved understanding of how YopM exerts
its anti-host effect in liver, where PMNs are critical cells that
YopM undermines, and YopM acts directly on cells without
involvement of a diffusible or mobile mediator. KCs lining the
sinusoids function to bind and clear LPS and bacteria from blood:
they have multiple receptors for polysaccharides that bind bacteria
Figure 5. YopM did not affect the distributions of inflammatory cells. Liver sections from the mice of Figure 3 were stained for inducible
nitric oxide synthase (iNOS; panels A and B), the KC/MO marker F4/80 (panels C), or the PMN marker Ly6G (panels D). Antigen detection used DAB
staining (black or brown) in sections from livers infected by parent Y. pestis (left panels) and the DYopM-1 strain (right panels). The arrows in panels C
point to inflammatory foci. The bars represent 100 mm (panels A, C, D) or 10 mm (panels B).
doi:10.1371/journal.pone.0110956.g005
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to their surfaces [31,32]. However, as exemplified by studies with
Listeria, Salmonella, Klebsiella, and Escherichia, early bacterial
killing in liver during systemic infection is largely accomplished by
PMNs that are rapidly attracted from the circulation by Il-1b and
IL-6 produced by KCs [31]. Our histological studies revealed that
the bacteria are associated with myeloid cells from 17 h to 2 d p.i.;
and by d 2 p.i. the presence of YopM in the infecting bacteria
resulted in increased death of inflammatory cells over that seen in
its absence. We speculate that this results from direct binding of
the bacteria with delivery of Yops into PMNs and macrophages.
In both spleen and liver, caspase-3 was identified as a co-factor
or effector in YopM’s action: caspase-3 function was required for
YopM to have its growth-promoting effect on the bacteria. This
novel finding implicates the existence of an anti-bacterial target
against which YopM directs caspase-3. Our data did not imply
that YopM modulates caspase-3 activity: rather that caspase-3 is
required for YopM to have its effect. Nonetheless, the presence of
YopM in the infecting Y. pestis was reflected in greater numbers of
dead inflammatory cells. This suggests that YopM acts directly or
indirectly with or downstream of activated caspase-3. In macro-
phages, YopJ’s inhibition of NF-kB and MAPKK kinase signaling
indirectly provides the caspase-3 activation that YopM requires for
its function [33,34]. In PMNs, caspase-3-dependent apoptosis is a
consequence of stimulation, but apoptosis is delayed by multiple
factors within a proinflammatory milieu [35]. Further, YopJ does
not cause apoptosis in PMNs, and several Y. pestis virulence
properties inhibit major inducers of apoptosis: the Pla protease
degrades Fas ligand, and YopH, YopE, and LcrV inhibit
phagocytosis, the respiratory burst, and production of large
amounts of TNFa [5,30,36]. It is tempting to speculate that
YopM functions in a pathway that tips the balance toward
caspase-3 activation and death of PMNs. Because PMNs otherwise
limit growth of Y. pestis in liver, a function of YopM to promote
apoptosis of these cells is a plausible pathogenic mechanism.
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Figure 6. Tests with mutant strains of mice revealed a host
factor with which YopM might act. Viable bacterial numbers for
parent and DyopM-1 Y. pestis were assayed on d 3 in livers and spleens
of mice from two experiments in which mice were infected with 500
parent or DyopM-1 Y. pestis grown at 28uC. Data for Casp32/2 mice
were pooled and represent responses in 8 (parent strain) or 12 (DyopM-
1 strain) mice per datum point. Data for B6 mice were pooled from 6
experiments and represent responses in 15 to 18 mice per datum point.
The bars give geometric means and the error bars indicate the standard
deviations. Significance of differences was assayed by the Student’s
two-tailed unpaired t test. *, P,0.05; **, P,0.01; ***, P,0.001; ****, P,
0.0001.
doi:10.1371/journal.pone.0110956.g006
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The pathway(s) through which YopM functions are beginning
to be assembled for macrophages. YopM invokes novel signaling
pathways by recruiting and activating kinases such as RSK1 and
PRK2 that do not normally work together [7], but the
downstream effects of these interactions have not yet been
determined. In the context of stimulatory LPS on the bacteria,
YopM also prevents maturation of the NLRP3, NLRC4, and
NLRP1 inflammasomes by preventing the activation of caspase-1
in macrophages [10]. One player in this mechanism is the scaffold
protein IQGAP1, which YopM was recently shown to bind [37].
YopM’s function in PMNs has not previously been examined. It is
intriguing that in PMNs IQGAP1 functions in a complex with the
chemokine receptor CXCR2 to mediate effects of CXCL1/KC
(CXCL8/IL-8 in human PMNs) and CXCL2/MIP-2a [38].
These effects include delaying both spontaneous and TNFa-
induced apoptosis [39,40]. Future studies are needed to learn
whether YopM binds IQGAP1 and inhibits CXCR2 signaling in
PMNs.
Supporting Information
Figure S1 Similar amounts of TUNEL staining were
present in spleens of mice infected with parent and
DyopM-1 Y. pestis. B6 mice were infected IV with 105 parent or
DyopM-1 Y. pestis grown at 28uC and recovered at d 2 p.i.
Sections of spleens and livers were stained by the TUNEL reaction
for cells undergoing DNA fragmentation (bright green fluores-
cence). Panels A and B illustrate the similar amounts of TUNEL+
nuclei due to the two Y. pestis strains in spleens. Panels C and D
illustrate the greater amount of TUNEL staining in liver foci due
to the parent strain (panel C) than to the DyopM-1 mutant (panel
D), as was seen in the experiments described in the main
Figure 7. Typical lesions in livers from B6 and Casp32/2 mice infected 3 d with a low dose of 286C-grown parent and DyopM-1 Y.
pestis. B6 and B6.129S1-Casp3tm1Flv/J knockout mice lacking active caspase-3 were infected IV with 100 to 500 parent or DyopM-1 Y. pestis grown at
28uC. On d 3 p.i., livers from mice infected by each Y. pestis strain in two independent experiments were recovered and sections were stained with
H&E (11 Casp32/2 and 6 B6 mice infected by each bacterial strain in two experiments were examined). Typical lesions in mice that had the same CFU
per liver as the means in Figure 6 are illustrated. Top panels (A, B), mice infected by parent Y. pestis (26106 CFU and 105 CFU in the respective mice).
Arrows point to foci. Bottom panels (C, D), mice infected with the DyopM-1 strain (46104 CFU and 26104 CFU in the respective mice. The bars all
represent 100 mm.
doi:10.1371/journal.pone.0110956.g007
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manuscript that used 104 thermally pre-induced bacteria. The
DAPI-stained nuclei in the same liver sections are shown below
their TUNEL counterparts in panels E and F. The foci in both
liver and spleen were quantified for percent of focus area that
contained green fluorescence brighter than background, and the
results are mentioned in the text. In all panels the bars represent
100 mm.
(TIF)
Table S1 Distribution of Ly6G+ and F4/80+ Cells in foci
after infection with thermally preinduced Y. pestis.
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